SELECTED PHYSICIAN PROFILES Dedicated to Discovery … Committed to Care www.dana-farber.org Table of Contents About Dana-Farber Cancer Institute Dana-Farber/NHOH Pediatric Hematologic Malignancies www.dana-farber.org 3 4 6 2 About Dana-Farber Cancer Institute For more than 60 years, Dana-Farber Cancer Institute has had one goal: to reduce the suffering caused by cancer through advanced clinical care and cutting-edge scientific research. As a principal teaching affiliate of Harvard Medical School, we are able to attract many of the best and brightest physicians in the world to pursue this mission. At Dana-Farber, we are committed to a multidisciplinary, compassionate, and collaborative model of care that truly puts patients and their families at the center of all we do. We work in teams organized around combating specific types of cancer, and patients have easy and direct access to the full range of specialists they may need. Our scientific research is focused on understanding the biology of cancer cells in order to develop more effective therapies that improve patient outcomes. Our lab scientists and clinicians collaborate closely to quickly translate findings from the lab into therapies that can be delivered to patients in our clinics. Dana-Farber is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), a NCIdesignated Comprehensive Cancer Center. DF/HCC harnesses the expertise and resources of DanaFarber and six other Harvard-affiliated hospitals and research institutions to conduct research focused on improving the understanding and treatment of cancer. Dana-Farber is also a founding member of the National Comprehensive Cancer Network, an alliance of the world’s leading cancer centers, working together to develop cancer treatment guidelines and research that improves the quality and effectiveness of cancer care. In addition, Dana-Farber has earned “Magnet” status, recognizing the Institute’s highquality patient care, nursing excellence, and innovations in professional nursing practice. www.dana-farber.org 3 Dana-Farber/NHOH Dana-Farber/New Hampshire Oncology-Hematology (Dana-Farber/NHOH) provides expert hematology and medical oncology treatment in Londonderry, NH. Through Dana-Farber/NHOH, patients receive the benefits of Dana-Farber's advances in care and research, while staying close to home. In addition, through monthly second-opinion consults, physicians and their patients can discuss diagnoses and treatment plans with Dana-Farber sub-specialists. The Center also provides an array of specialized and support services to patients and families, including select Dana-Farber clinical trials, high-risk screening and genetic counseling, nutrition services and survivorship,. New Patient Appointment Phone: 603-552-9100 Fax: 603-552-9111 Leadership - Dana-Farber/NHOH Jeanna Walsh, MD, Medical Director Treatment Team Hematology/Oncology Frederick M. Briccetti, MD Meredith J. Selleck, MD Jeanna H. Walsh, MD To make an appointment, call (603) 552-9100. www.dana-farber.org/londonderry 4 Dana-Farber/NHOH - Hematology/Oncology Jeanna H. Walsh, MD Leadership Title: Medical Director, Dana-Farber/New Hampshire Oncology-Hematology Academic Title: Instructor in Medicine, Harvard Medical School Discipline: Hematologist/Oncologist Phone: 603-552-9100 Fax: 603-552-9105 Residency: Strong Memorial Hospital, Internal Medicine Fellowship: Strong Memorial Hospital, Hematology and Oncology Board Certifications: Hematology Internal Medicine Oncology E-mail: [email protected] Medical School: Upstate Medical University To make an appointment, call (603) 552-9100. www.dana-farber.org/londonderry 5 Pediatric Hematologic Malignancies The hematologic malignancies team at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is recognized for its expertise in treating leukemia and lymphoma (including Hodgkin and non-Hodgkin lymphoma), diseases that comprise approximately one-third of all childhood cancer cases. Our physicians head the Dana-Farber Cancer Institute ALL Consortium, an international organization focused on acute lymphoblastic leukemia (ALL) treatment and research. Our treatment results for children with newly diagnosed ALL are among the best published cure rates. New Patient Appointment Phone: 617-632-5508 or 888-733-4662 Fax: 617-582-7434 Email: [email protected] Leadership - Pediatric Hematologic Malignancies Center Lewis Silverman, MD, Clinical Director, Hematologic Malignancies Center Treatment Team Pathology Mark D. Fleming, MD, DPhil Marian Harris, MD Olga K. Weinberg, MD Hematology/Oncology Prasanna Ananth, MD, MPH Shelly C. Bernstein, MD, PhD Amy L. Billett, MD Kira Bona, MD, MPH Brian D. Crompton, MD Kimberly J. Davies, MD Barbara A. Degar, MD Erica Esrick, MD Paola M. Friedrich, MD, MPH Alejandro Gutierrez, MD Andrew L. Hong, MD Jennifer C. Kesselheim, MD, M.Ed, MBE Birgit Knoechel, MD, PhD Brenton Mar, MD, PhD Stuart H. Orkin, MD Barry H. Paw, MD, PhD Andrew E. Place, MD, PhD Raffaele Renella, MD, PhD Stephen E. Sallan, MD Lewis B. Silverman, MD Kimberly Stegmaier, MD Lynda M. Vrooman, MD Loren D. Walensky, MD, PhD Joanna S. Yi, MD Radiation Oncology Alan D. D'Andrea, MD Karen J. Marcus, MD To make an appointment, please call (888) 733-4662 www.danafarberbostonchildrens.org 6 Pediatric Hematologic Malignancies - Hematology/Oncology Loren D. Walensky, MD, PhD Academic Title: Associate Professor of Pediatrics, Harvard Medical School Discipline: Pediatric Hematologist/Oncologist Phone: 617-632-6307 Fax: 617-582-8240 E-mail: [email protected] Fellowship: Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology Board Certifications: Pediatrics Pediatric Hematology/Oncology Area of Expertise: Hematologic malignancies Medical School: Johns Hopkins University School of Medicine Residency: Boston Combined Residency Program, Boston Children's Hospital/Boston Medical Center, Pediatrics To make an appointment, please call (888) 733-4662 www.danafarberbostonchildrens.org 7